Stay updated on XEN1101 Adjunct Therapy in Generalized Seizures Clinical Trial
Sign up to get notified when there's something new on the XEN1101 Adjunct Therapy in Generalized Seizures Clinical Trial page.

Latest updates to the XEN1101 Adjunct Therapy in Generalized Seizures Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1.0%
- Check9 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe page has been updated to reflect an increase in study locations from 125 to 129, with new recruiting sites added in Tucson, Clinton, Charlotte, and Chieti. Additionally, the revision number has been updated from v2.15.0 to v2.15.2.SummaryDifference2%
- Check45 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed descriptions of a Phase 3 clinical trial for XEN1101 and the addition of a new revision number. The names of collaborators and the trial number have also been updated.SummaryDifference24%
- Check52 days agoChange DetectedThe page now indicates that the study has increased to 125 locations and has withdrawn the recruitment status for a specific site in Lyon, France.SummaryDifference0.9%
- Check60 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of March 5, 2025, and version 2.14.2.SummaryDifference0.1%
Stay in the know with updates to XEN1101 Adjunct Therapy in Generalized Seizures Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XEN1101 Adjunct Therapy in Generalized Seizures Clinical Trial page.